Let's K-Talk - HPV Study for Ethnic Koreans

Running, not enrolling · Not applicable

Conditions studied: Human Papillomavirus Viruses, Papillomavirus Vaccines

In brief

The goal of this clinical trial is to test the feasibility, acceptability, and preliminary efficacy of a storytelling video-based intervention using AI chatbot technology (K-Talk) to promote HPV vaccination behavior among Korean Americans aged 18 to 45. The main questions this study aims to answer are: * Is the K-Talk intervention feasible for use among Korean Americans aged 18 to 45? * Is the K-Talk intervention acceptable to the target population? * What is the preliminary efficacy of the K-Talk intervention in promoting HPV vaccination uptake? Participants will be Korean Americans aged 18 to 45 who are at risk for HPV infection. Participants will be asked to complete a baseline survey and then will be "randomized" into one of four groups: Group 1 (chatbot + storytelling intervention), Group 2 (chatbot only), Group 3 (storytelling only), and Group 4 will be only exposed to written didactic HPV education materials. All groups will receive written didactic HPV education materials. Researchers will compare how Group 1, a combination of AI Chatbot and storytelling intervention is more effective than other intervention groups in promoting HPV vaccination uptake among underserved, hard-to-reach Korean Americans.

Key facts

Study ID

NCT05884697

Run by

University of Cincinnati

People needed

120

Starts

2023-05-10

Expected to finish

2026-07-31

Last updated by the study team

2025-08-17

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Identify as a Korean ethnic person
• Reside in the U.S.
• between the ages of 18 and 45
• be able to speak or read English
• not have been vaccinated against HPV
• use a mobile device.

You may not qualify if…

• Participants who do not identify as a Korean ethnic person
• Participants who do not reside in the U.S.
• Participants who are not between the ages of 18 and 45.
• Participants who cannot speak or read English.
• Participants who have been vaccinated against HPV.
• Participants who do not use a mobile device.

Where it is running

• Minjin Kim — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.